1
|
Nicholson N, Perego A. Interoperability of population-based patient registries. J Biomed Inform 2020; 112S:100074. [PMID: 32838295 PMCID: PMC7293468 DOI: 10.1016/j.yjbinx.2020.100074] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Revised: 04/29/2020] [Accepted: 05/14/2020] [Indexed: 12/04/2022]
Abstract
Inter-linkage of patient-registry data provides a rich source of secondary data usage. Mapping of heterogeneous metadata systems can be accomplished via semantic links. Semantic linkage between patient registries provides the basis for interoperability. Semantic metadata registry frameworks can facilitate access back to primary data sources.
Enabling full interoperability within and between population-based patient-registry domains would open up access to a rich and unique source of health data for secondary data usage. Previous attempts to tackle patient-registry interoperability have met with varying degrees of success, but a unifying solution remains elusive. The purpose of this paper is to show by practical example how a solution is attainable via the implementation of an existing framework based of the concept of federated, semantic metadata registries. One important feature motivating the use of this framework is that it can be implemented gradually and independently within each patient-registry domain. By employing linked open data principles, the framework extends the ISO/IEC 11179 standard to provide both syntactic and semantic interoperability of data elements with the means of specifying automated extraction scripts for retrieval of data from different registry content models. The examples provided address the domain of European population-based cancer registries to demonstrate the feasibility of the approach. One of the examples shows how quick gains are derivable by allowing retrieval of aggregated core data sets. The other examples show how aggregated full sets of data and record-level data might also be retrieved from each local registry. An infrastructure of patient-registry domains adhering to the principles of the framework would provide the semantic contexts and inter-linkage of data necessary for automated search and retrieval of registry data. It would thereby also lay the foundation for making registry data serviceable to artificial intelligence (AI) applications.
Collapse
|
2
|
Zeng ISL, Lumley T. Review of Statistical Learning Methods in Integrated Omics Studies (An Integrated Information Science). Bioinform Biol Insights 2018; 12:1177932218759292. [PMID: 29497285 PMCID: PMC5824897 DOI: 10.1177/1177932218759292] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Accepted: 01/24/2018] [Indexed: 12/14/2022] Open
Abstract
Integrated omics is becoming a new channel for investigating the complex molecular system in modern biological science and sets a foundation for systematic learning for precision medicine. The statistical/machine learning methods that have emerged in the past decade for integrated omics are not only innovative but also multidisciplinary with integrated knowledge in biology, medicine, statistics, machine learning, and artificial intelligence. Here, we review the nontrivial classes of learning methods from the statistical aspects and streamline these learning methods within the statistical learning framework. The intriguing findings from the review are that the methods used are generalizable to other disciplines with complex systematic structure, and the integrated omics is part of an integrated information science which has collated and integrated different types of information for inferences and decision making. We review the statistical learning methods of exploratory and supervised learning from 42 publications. We also discuss the strengths and limitations of the extended principal component analysis, cluster analysis, network analysis, and regression methods. Statistical techniques such as penalization for sparsity induction when there are fewer observations than the number of features and using Bayesian approach when there are prior knowledge to be integrated are also included in the commentary. For the completeness of the review, a table of currently available software and packages from 23 publications for omics are summarized in the appendix.
Collapse
Affiliation(s)
- Irene Sui Lan Zeng
- Department of Statistics, Faculty of Science, The University of Auckland, Auckland, New Zealand
| | - Thomas Lumley
- Department of Statistics, Faculty of Science, The University of Auckland, Auckland, New Zealand
| |
Collapse
|
3
|
Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer. BIOMED RESEARCH INTERNATIONAL 2017; 2017:8327980. [PMID: 29214177 PMCID: PMC5682045 DOI: 10.1155/2017/8327980] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/03/2017] [Revised: 06/11/2017] [Accepted: 10/02/2017] [Indexed: 12/28/2022]
Abstract
Patient registries are an essential tool to increase current knowledge regarding rare diseases. Understanding these data is a vital step to improve patient treatments and to create the most adequate tools for personalized medicine. However, the growing number of disease-specific patient registries brings also new technical challenges. Usually, these systems are developed as closed data silos, with independent formats and models, lacking comprehensive mechanisms to enable data sharing. To tackle these challenges, we developed a Semantic Web based solution that allows connecting distributed and heterogeneous registries, enabling the federation of knowledge between multiple independent environments. This semantic layer creates a holistic view over a set of anonymised registries, supporting semantic data representation, integrated access, and querying. The implemented system gave us the opportunity to answer challenging questions across disperse rare disease patient registries. The interconnection between those registries using Semantic Web technologies benefits our final solution in a way that we can query single or multiple instances according to our needs. The outcome is a unique semantic layer, connecting miscellaneous registries and delivering a lightweight holistic perspective over the wealth of knowledge stemming from linked rare disease patient registries.
Collapse
|
4
|
SCALEUS: Semantic Web Services Integration for Biomedical Applications. J Med Syst 2017; 41:54. [PMID: 28214993 DOI: 10.1007/s10916-017-0705-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Accepted: 02/09/2017] [Indexed: 10/20/2022]
Abstract
In recent years, we have witnessed an explosion of biological data resulting largely from the demands of life science research. The vast majority of these data are freely available via diverse bioinformatics platforms, including relational databases and conventional keyword search applications. This type of approach has achieved great results in the last few years, but proved to be unfeasible when information needs to be combined or shared among different and scattered sources. During recent years, many of these data distribution challenges have been solved with the adoption of semantic web. Despite the evident benefits of this technology, its adoption introduced new challenges related with the migration process, from existent systems to the semantic level. To facilitate this transition, we have developed Scaleus, a semantic web migration tool that can be deployed on top of traditional systems in order to bring knowledge, inference rules, and query federation to the existent data. Targeted at the biomedical domain, this web-based platform offers, in a single package, straightforward data integration and semantic web services that help developers and researchers in the creation process of new semantically enhanced information systems. SCALEUS is available as open source at http://bioinformatics-ua.github.io/scaleus/ .
Collapse
|
5
|
Sernadela P, Oliveira JL. A semantic-based workflow for biomedical literature annotation. Database (Oxford) 2017; 2017:4635750. [PMID: 29220478 PMCID: PMC5691355 DOI: 10.1093/database/bax088] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Revised: 10/02/2017] [Accepted: 10/30/2017] [Indexed: 11/12/2022]
Abstract
Computational annotation of textual information has taken on an important role in knowledge extraction from the biomedical literature, since most of the relevant information from scientific findings is still maintained in text format. In this endeavour, annotation tools can assist in the identification of biomedical concepts and their relationships, providing faster reading and curation processes, with reduced costs. However, the separate usage of distinct annotation systems results in highly heterogeneous data, as it is difficult to efficiently combine and exchange this valuable asset. Moreover, despite the existence of several annotation formats, there is no unified way to integrate miscellaneous annotation outcomes into a reusable, sharable and searchable structure. Taking up this challenge, we present a modular architecture for textual information integration using semantic web features and services. The solution described allows the migration of curation data into a common model, providing a suitable transition process in which multiple annotation data can be integrated and enriched, with the possibility of being shared, compared and reused across semantic knowledge bases.
Collapse
Affiliation(s)
- Pedro Sernadela
- University of Aveiro, DETI/IEETA, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal
| | - José Luís Oliveira
- University of Aveiro, DETI/IEETA, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal
| |
Collapse
|
6
|
Lopes P, Oliveira JL. An automated real-time integration and interoperability framework for bioinformatics. BMC Bioinformatics 2015; 16:328. [PMID: 26464306 PMCID: PMC4603302 DOI: 10.1186/s12859-015-0761-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 10/06/2015] [Indexed: 11/29/2022] Open
Abstract
Background In recent years data integration has become an everyday undertaking for life sciences researchers. Aggregating and processing data from disparate sources, whether through specific developed software or via manual processes, is a common task for scientists. However, the scope and usability of the majority of current integration tools fail to deal with the fast growing and highly dynamic nature of biomedical data. Results In this work we introduce a reactive and event-driven framework that simplifies real-time data integration and interoperability. This platform facilitates otherwise difficult tasks, such as connecting heterogeneous services, indexing, linking and transferring data from distinct resources, or subscribing to notifications regarding the timeliness of dynamic data. For developers, the framework automates the deployment of integrative and interoperable bioinformatics applications, using atomic data storage for content change detection, and enabling agent-based intelligent extract, transform and load tasks. Conclusions This work bridges the gap between the growing number of services, accessing specific data sources or algorithms, and the growing number of users, performing simple integration tasks on a recurring basis, through a streamlined workspace available to researchers and developers alike.
Collapse
Affiliation(s)
- Pedro Lopes
- DETI/IEETA, Universidade de Aveiro, Campus Universitario de Santiago, Aveiro, 3810-193, Portugal.
| | - José Luís Oliveira
- DETI/IEETA, Universidade de Aveiro, Campus Universitario de Santiago, Aveiro, 3810-193, Portugal.
| |
Collapse
|
7
|
Schweiger D, Trajanoski Z, Pabinger S. SPARQLGraph: a web-based platform for graphically querying biological Semantic Web databases. BMC Bioinformatics 2014; 15:279. [PMID: 25127889 PMCID: PMC4148538 DOI: 10.1186/1471-2105-15-279] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2014] [Accepted: 08/12/2014] [Indexed: 05/28/2023] Open
Abstract
Background Semantic Web has established itself as a framework for using and sharing data across applications and database boundaries. Here, we present a web-based platform for querying biological Semantic Web databases in a graphical way. Results SPARQLGraph offers an intuitive drag & drop query builder, which converts the visual graph into a query and executes it on a public endpoint. The tool integrates several publicly available Semantic Web databases, including the databases of the just recently released EBI RDF platform. Furthermore, it provides several predefined template queries for answering biological questions. Users can easily create and save new query graphs, which can also be shared with other researchers. Conclusions This new graphical way of creating queries for biological Semantic Web databases considerably facilitates usability as it removes the requirement of knowing specific query languages and database structures. The system is freely available at http://sparqlgraph.i-med.ac.at.
Collapse
Affiliation(s)
| | | | - Stephan Pabinger
- Division for Bioinformatics, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
| |
Collapse
|
8
|
Thompson R, Johnston L, Taruscio D, Monaco L, Béroud C, Gut IG, Hansson MG, ’t Hoen PBA, Patrinos GP, Dawkins H, Ensini M, Zatloukal K, Koubi D, Heslop E, Paschall JE, Posada M, Robinson PN, Bushby K, Lochmüller H. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J Gen Intern Med 2014; 29 Suppl 3:S780-7. [PMID: 25029978 PMCID: PMC4124112 DOI: 10.1007/s11606-014-2908-8] [Citation(s) in RCA: 104] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Research into rare diseases is typically fragmented by data type and disease. Individual efforts often have poor interoperability and do not systematically connect data across clinical phenotype, genomic data, biomaterial availability, and research/trial data sets. Such data must be linked at both an individual-patient and whole-cohort level to enable researchers to gain a complete view of their disease and patient population of interest. Data access and authorization procedures are required to allow researchers in multiple institutions to securely compare results and gain new insights. Funded by the European Union's Seventh Framework Programme under the International Rare Diseases Research Consortium (IRDiRC), RD-Connect is a global infrastructure project initiated in November 2012 that links genomic data with registries, biobanks, and clinical bioinformatics tools to produce a central research resource for rare diseases.
Collapse
Affiliation(s)
- Rachel Thompson
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| | - Louise Johnston
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| | | | | | - Christophe Béroud
- />Aix Marseille Université, INSERM, GMGF UMR_S 910, 13385 Marseille, France
| | - Ivo G. Gut
- />Centre Nacional d’Anàlisi Genòmica, Barcelona, Spain
| | | | | | | | - Hugh Dawkins
- />Office of Population Health Genomics, Department of Health Western Australia, Perth, Australia
| | - Monica Ensini
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| | | | | | - Emma Heslop
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| | - Justin E. Paschall
- />European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK
| | - Manuel Posada
- />Instituto de Salud Carlos III, Instituto de Investigación de Enfermedades Raras, CIBERER, Madrid, Spain
| | - Peter N. Robinson
- />Institute for Medical Genetics and Human Genetics, Charité-Universitätsmedizin, Berlin, Germany
| | - Kate Bushby
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| | - Hanns Lochmüller
- />Institute of Genetic Medicine, MRC Centre for Neuromuscular Diseases, Newcastle University, London, UK
| |
Collapse
|
9
|
Gathering and exploring scientific knowledge in pharmacovigilance. PLoS One 2013; 8:e83016. [PMID: 24349421 PMCID: PMC3859628 DOI: 10.1371/journal.pone.0083016] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2013] [Accepted: 11/08/2013] [Indexed: 11/19/2022] Open
Abstract
Pharmacovigilance plays a key role in the healthcare domain through the assessment, monitoring and discovery of interactions amongst drugs and their effects in the human organism. However, technological advances in this field have been slowing down over the last decade due to miscellaneous legal, ethical and methodological constraints. Pharmaceutical companies started to realize that collaborative and integrative approaches boost current drug research and development processes. Hence, new strategies are required to connect researchers, datasets, biomedical knowledge and analysis algorithms, allowing them to fully exploit the true value behind state-of-the-art pharmacovigilance efforts. This manuscript introduces a new platform directed towards pharmacovigilance knowledge providers. This system, based on a service-oriented architecture, adopts a plugin-based approach to solve fundamental pharmacovigilance software challenges. With the wealth of collected clinical and pharmaceutical data, it is now possible to connect knowledge providers' analysis and exploration algorithms with real data. As a result, new strategies allow a faster identification of high-risk interactions between marketed drugs and adverse events, and enable the automated uncovering of scientific evidence behind them. With this architecture, the pharmacovigilance field has a new platform to coordinate large-scale drug evaluation efforts in a unique ecosystem, publicly available at http://bioinformatics.ua.pt/euadr/.
Collapse
|
10
|
An innovative portal for rare genetic diseases research: the semantic Diseasecard. J Biomed Inform 2013; 46:1108-15. [PMID: 23973272 DOI: 10.1016/j.jbi.2013.08.006] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2013] [Revised: 06/26/2013] [Accepted: 08/13/2013] [Indexed: 12/17/2022]
Abstract
Advances in "omics" hardware and software technologies are bringing rare diseases research back from the sidelines. Whereas in the past these disorders were seldom considered relevant, in the era of whole genome sequencing the direct connections between rare phenotypes and a reduced set of genes are of vital relevance. This increased interest in rare genetic diseases research is pushing forward investment and effort towards the creation of software in the field, and leveraging the wealth of available life sciences data. Alas, most of these tools target one or more rare diseases, are focused solely on a single type of user, or are limited to the most relevant scientific breakthroughs for a specific niche. Furthermore, despite some high quality efforts, the ever-growing number of resources, databases, services and applications is still a burden to this area. Hence, there is a clear interest in new strategies to deliver a holistic perspective over the entire rare genetic diseases research domain. This is Diseasecard's reasoning, to build a true lightweight knowledge base covering rare genetic diseases. Developed with the latest semantic web technologies, this portal delivers unified access to a comprehensive network for researchers, clinicians, patients and bioinformatics developers. With in-context access covering over 20 distinct heterogeneous resources, Diseasecard's workspace provides access to the most relevant scientific knowledge regarding a given disorder, whether through direct common identifiers or through full-text search over all connected resources. In addition to its user-oriented features, Diseasecard's semantic knowledge base is also available for direct querying, enabling everyone to include rare genetic diseases knowledge in new or existing information systems. Diseasecard is publicly available at http://bioinformatics.ua.pt/diseasecard/.
Collapse
|